{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:42:47Z","timestamp":1789386167563,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12936-017-1825-9","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T12:29:44Z","timestamp":1493036984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Ivermectin and malaria control"],"prefix":"10.1186","volume":"16","author":[{"given":"Satoshi","family":"\u014cmura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5299-1489","authenticated-orcid":false,"given":"Andy","family":"Crump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"key":"1825_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-1801-4","author":"C Chaccour","year":"2017","unstructured":"Chaccour C, Hammann F, Rabinovich NR. Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety. Malar J. 2017. doi: 10.1186\/s12936-017-1801-4 .","journal-title":"Malar J."},{"key":"1825_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-1802-3","author":"CJ Chaccour","year":"2017","unstructured":"Chaccour CJ, Rabinovich NR. Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway. Malar J. 2017. doi: 10.1186\/s12936-017-1802-3 .","journal-title":"Malar J."},{"key":"1825_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-1803-2","author":"CJ Chaccour","year":"2017","unstructured":"Chaccour CJ, Rabinovich NR. Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways. Malar J. 2017. doi: 10.1186\/s12936-017-1803-2 .","journal-title":"Malar J."},{"key":"1825_CR4","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/nrmicro1048","volume":"2","author":"S \u014cmura","year":"2005","unstructured":"\u014cmura S, Crump A. The life and times of ivermectin: a success story. Nat Rev Microbiol. 2005;2:984\u20139.","journal-title":"Nat Rev Microbiol"},{"key":"1825_CR5","unstructured":"WHO. Update on the global status of implementation of preventive chemotherapy. (PC); 8th March 2017. Accessed 9 Mar 2017."},{"key":"1825_CR6","unstructured":"ESPEN. http:\/\/www.afro.who.int\/en\/espen\/about.html . Accessed 19 Apr 2017."},{"key":"1825_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4269\/ajtmh.1990.43.229","volume":"43","author":"RB Tesh","year":"1990","unstructured":"Tesh RB, Guzman H. Mortality and infertility in adult mosquitoes after the ingestion of blood containing ivermectin. Am J Trop Med Hyg. 1990;43:229\u201333.","journal-title":"Am J Trop Med Hyg"},{"key":"1825_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1086\/653208","volume":"202","author":"C Chaccour","year":"2010","unstructured":"Chaccour C, Lines J, Whitty CJM. Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans; the potential of oral insecticides in malaria control. J Infect Dis. 2010;202:113\u20136.","journal-title":"J Infect Dis"},{"key":"1825_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.actatropica.2010.06.001","volume":"116","author":"KC Kobylinski","year":"2010","unstructured":"Kobylinski KC, Deus KM, Butters MP, Hongyu T, Gray M, da Silva IM, et al. The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors. Acta Trop. 2010;116:119\u201326.","journal-title":"Acta Trop"},{"key":"1825_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4269\/ajtmh.2011.11-0160","volume":"85","author":"KC Kobylinski","year":"2011","unstructured":"Kobylinski KC, Sylla M, Chapman PL, Sarr MD, Foy BD. Ivermectin mass drug administration for humans disrupts malaria parasite transmission in Senegalese villages. Am J Trop Med Hyg. 2011;85:3\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"1825_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.pt.2011.05.007","volume":"27","author":"BD Foy","year":"2011","unstructured":"Foy BD, Kobylinski KC, da Silva IM, Rasgon JL, Sylla M. Endectocides for malaria control. Trends Parasitol. 2011;27:423\u20138.","journal-title":"Trends Parasitol"},{"key":"1825_CR12","doi-asserted-by":"publisher","first-page":"e994","DOI":"10.1038\/cddis.2013.521","volume":"16","author":"M Panchal","year":"2014","unstructured":"Panchal M, Rawat K, Kumar G, Kibria KM, Singh S, Kalamuddin M, et al. Plasmodium falciparum signal recognition particle components and anti-parasitic effect of ivermectin in blocking nucleo-cytoplasmic shuttling of SRP. Cell Death Dis. 2014;16:e994.","journal-title":"Cell Death Dis"},{"key":"1825_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12936-015-0691-6","volume":"14","author":"CJ Chaccour","year":"2015","unstructured":"Chaccour CJ, Rabinovich NR, Slater H, Canavati SE, Bousema T, Lacerda M, et al. Establishment of the ivermectin research for malaria elimination network: updating the research agenda. Malar J. 2015;14:243.","journal-title":"Malar J"},{"key":"1825_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2017.11","author":"A Crump","year":"2017","unstructured":"Crump A. Ivermectin: enigmatic multifaceted \u2018wonder\u2019 drug continues to surprise and exceed expectations. J Antibiot. 2017. doi: 10.1038\/ja.2017.11 (Epub ahead of print).","journal-title":"J Antibiot."},{"key":"1825_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0169-4758(85)90100-0","volume":"1","author":"WC Campbell","year":"1985","unstructured":"Campbell WC. Ivermectin: an update. Parasitol Today. 1985;1:10\u20136.","journal-title":"Parasitol Today"},{"key":"1825_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2017.31","author":"N Katz","year":"2017","unstructured":"Katz N, Ara\u00fajo N, Coelho PM, Morel CM, Linde-Arias AR, Yamada T, et al. Ivermectin efficacy against Biomphalaria, intermediate host snail vectors of Schistosomiasis. J Antibiot. 2017. doi: 10.1038\/ja.2017.31 (Epub ahead of print).","journal-title":"J Antibiot."},{"key":"1825_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-4612-3626-9_7","volume-title":"Ivermectin and abamectin","author":"DW Fink","year":"1989","unstructured":"Fink DW, Porras AG. Pharmacokinetics of ivermectin in animals and humans. In: Campbell WC, editor. Ivermectin and abamectin. Springer: New York; 1989. p. 113\u201330."},{"key":"1825_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s002280050131","volume":"50","author":"OZ Baraka","year":"1996","unstructured":"Baraka OZ, Mahmoud BM, Marschke CK, Geary TG, Homeida MM, Williams JF. Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus. Eur J Clin Pharmacol. 1996;50:407\u201310.","journal-title":"Eur J Clin Pharmacol"},{"key":"1825_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1208\/s12248-007-9000-9","volume":"10","author":"Canga A Gonz\u00e1lez","year":"2008","unstructured":"Gonz\u00e1lez Canga A, Sahag\u00fan Prieto AM, Diez Li\u00e9bana MJ, Fern\u00e1ndez Mart\u00ednez N, Sierra Vega M, Garc\u00eda Vieitez JJ. The pharmacokinetics and interactions of ivermectin in humans\u2014a mini-review. AAPS J. 2008;10:42\u20136.","journal-title":"AAPS J"},{"key":"1825_CR20","unstructured":"WHO. Global technical strategy for malaria 2016\u20132030. Geneva: World Health Organization; 2015. http:\/\/www.who.int\/malaria\/areas\/global_technical_strategy . Accessed 19 Apr 2017."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-1825-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T15:25:09Z","timestamp":1569079509000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-1825-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1825"],"URL":"https:\/\/doi.org\/10.1186\/s12936-017-1825-9","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,24]]},"article-number":"172"}}